# Cero Therapeutics Holdings, Inc.: Form 8-K, filed Aug 31, 2026

- Company: [Cero Therapeutics Holdings, Inc.](/companies/cero.md) (CIK 1870404)
- Form: 8-K
- Filed: 2026-08-31
- Accepted by EDGAR: Aug 31, 2026, 16:52 ET
- Period: 2026-08-27
- Accession: 0001213900-26-095776
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/ea0304037-8k_cero.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/ea0304037-8k_cero.htm

Filed Aug 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-095776. Last ingested by Listed: Nov 14, 2026, 19:08 ET. No prices; not investment advice.
